1. Wang, Dazhi, Liu, HuaQiang, Ren, Chunling, Wang, Lanying. 2019. High Expression of ABRACL Is Associated with Tumorigenesis and Affects Clinical Outcome in Gastric Cancer. In Genetic testing and molecular biomarkers, 23, 91-97. doi:10.1089/gtmb.2018.0195. https://pubmed.ncbi.nlm.nih.gov/30676103/
2. Fan, Shengming, Chen, Pei, Li, Shugang. 2021. miR-145-5p Inhibits the Proliferation, Migration, and Invasion of Esophageal Carcinoma Cells by Targeting ABRACL. In BioMed research international, 2021, 6692544. doi:10.1155/2021/6692544. https://pubmed.ncbi.nlm.nih.gov/33728339/
3. Eugene, Andy R, Masiak, Jolanta, Eugene, Beata. 2018. Predicting lithium treatment response in bipolar patients using gender-specific gene expression biomarkers and machine learning. In F1000Research, 7, 474. doi:10.12688/f1000research.14451.3. https://pubmed.ncbi.nlm.nih.gov/30828420/
4. Li, Jie, Chen, Hui. . Actin-binding Rho activating C-terminal like (ABRACL) transcriptionally regulated by MYB proto-oncogene like 2 (MYBL2) promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells. In Bioengineered, 13, 9019-9031. doi:10.1080/21655979.2022.2056821. https://pubmed.ncbi.nlm.nih.gov/35341461/
5. Chen, Yuanbin, Xu, Ting, Xie, Fei, Yang, Xuecheng, Jiao, Wei. 2020. Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer. In Oncology reports, 45, 191-201. doi:10.3892/or.2020.7853. https://pubmed.ncbi.nlm.nih.gov/33200223/
智鼠故事 
